Format

Send to

Choose Destination
Lasers Med Sci. 2013 Nov;28(6):1527-32. doi: 10.1007/s10103-012-1247-4. Epub 2013 Jan 29.

A metabolomic study on the effect of intravascular laser blood irradiation on type 2 diabetic patients.

Author information

1
Department of Medical Genetics, Tehran University of Medical Sciences, Tehran, Iran, kazemikho@razi.tums.ac.ir.

Abstract

Intravenous laser blood irradiation (ILBI) is widely applied in the treatment of different pathologies including diabetes mellitus. The aim of this study is to evaluate the effects of ILBI on the metabolites of blood in diabetic type 2 patients using metabolomics. We compared blood samples of nine diabetic type 2 patients, using metabolomics, before and after ILBI with blue light laser. The results showed significant decrease in glucose, glucose 6 phosphate, dehydroascorbic acid, R-3-hydroxybutyric acid, L-histidine, and L-alanine and significant increase in L-arginine level in blood and blood sugar in the patients have reduced significantly (pā€‰<ā€‰0.05). This study clearly demonstrated a significant positive effect of ILBI on metabolites of blood in diabetic type 2 patients. These findings support the therapeutic potential of ILBI in diabetic patients.

PMID:
23358875
DOI:
10.1007/s10103-012-1247-4
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center